|
EP1012151B1
(en)
*
|
1997-09-02 |
2002-08-07 |
Bristol-Myers Squibb Pharma Company |
Heterocyclyl-substituted ring-fused pyridines and pyrimidines as corticotropin releasing hormone (crh) antagonists, useful for treating cns and stress-related disorders
|
|
US6040315A
(en)
*
|
1997-10-30 |
2000-03-21 |
Day; Charles E. |
Antacid co-polymer of guanidine and polyethylenimine
|
|
DE19844291A1
(de)
*
|
1998-09-18 |
2000-03-23 |
Schering Ag |
Benzoxazin- und Benzothiazin-Derivate und deren Verwendung in Arzneimitteln
|
|
GB9828511D0
(en)
|
1998-12-24 |
1999-02-17 |
Zeneca Ltd |
Chemical compounds
|
|
AU768201B2
(en)
*
|
1999-01-22 |
2003-12-04 |
Amgen, Inc. |
Kinase inhibitors
|
|
US6495558B1
(en)
|
1999-01-22 |
2002-12-17 |
Amgen Inc. |
Kinase inhibitors
|
|
ATE277064T1
(de)
|
1999-05-26 |
2004-10-15 |
Hoffmann La Roche |
Verfahren zur herstellung von vinylpyrimidinderivaten
|
|
DE60005526T2
(de)
*
|
1999-07-30 |
2004-07-01 |
Pharmagene Laboratories Ltd. |
Verwendung von 2-amino-4-(4-fluoronaphth-1-yl)-6-isopropylpyrimidine zur behandlung von erkrankungen des magen-darm-traktes
|
|
GB9919778D0
(en)
|
1999-08-21 |
1999-10-27 |
Zeneca Ltd |
Chemical compounds
|
|
DE60023926T2
(de)
|
1999-09-10 |
2006-07-20 |
Merck & Co., Inc. |
Tyrosin kinase inhibitoren
|
|
US7101869B2
(en)
|
1999-11-30 |
2006-09-05 |
Pfizer Inc. |
2,4-diaminopyrimidine compounds useful as immunosuppressants
|
|
JP4064671B2
(ja)
*
|
2000-02-25 |
2008-03-19 |
エフ．ホフマン−ラ ロシュ アーゲー |
アデノシン受容体モジュレーター
|
|
GB0004888D0
(en)
|
2000-03-01 |
2000-04-19 |
Astrazeneca Uk Ltd |
Chemical compounds
|
|
GB0004886D0
(en)
|
2000-03-01 |
2000-04-19 |
Astrazeneca Uk Ltd |
Chemical compounds
|
|
GB0004887D0
(en)
|
2000-03-01 |
2000-04-19 |
Astrazeneca Uk Ltd |
Chemical compounds
|
|
GB0004890D0
(en)
|
2000-03-01 |
2000-04-19 |
Astrazeneca Uk Ltd |
Chemical compounds
|
|
GB0007371D0
(en)
|
2000-03-28 |
2000-05-17 |
Astrazeneca Uk Ltd |
Chemical compounds
|
|
GB0016877D0
(en)
|
2000-07-11 |
2000-08-30 |
Astrazeneca Ab |
Chemical compounds
|
|
GB0021726D0
(en)
|
2000-09-05 |
2000-10-18 |
Astrazeneca Ab |
Chemical compounds
|
|
US6444477B1
(en)
|
2000-11-28 |
2002-09-03 |
Pharmagene Laboratories Limited |
Assay method for detecting 5-HT2B antagonists
|
|
GB0103926D0
(en)
|
2001-02-17 |
2001-04-04 |
Astrazeneca Ab |
Chemical compounds
|
|
CA2446980A1
(en)
*
|
2001-05-14 |
2002-11-21 |
Argyrios G. Arvanitis |
Substituted pyrazinones, pyridines and pyrimidines as corticotropin releasing factor ligands
|
|
GB0113041D0
(en)
|
2001-05-30 |
2001-07-18 |
Astrazeneca Ab |
Chemical compounds
|
|
JP2005500294A
(ja)
*
|
2001-06-19 |
2005-01-06 |
ブリストル−マイヤーズ スクイブ カンパニー |
ホスホジエステラーゼ７に対するピリミジン阻害剤
|
|
US6825198B2
(en)
*
|
2001-06-21 |
2004-11-30 |
Pfizer Inc |
5-HT receptor ligands and uses thereof
|
|
ATE316088T1
(de)
|
2001-06-22 |
2006-02-15 |
Merck & Co Inc |
Tyrosin-kinase inhibitoren
|
|
TWI329105B
(en)
*
|
2002-02-01 |
2010-08-21 |
Rigel Pharmaceuticals Inc |
2,4-pyrimidinediamine compounds and their uses
|
|
GB0203412D0
(en)
|
2002-02-13 |
2002-04-03 |
Pharmagene Lab Ltd |
5-HT 2B receptor antagonists
|
|
EP1474141A1
(en)
*
|
2002-02-13 |
2004-11-10 |
Pharmagene Laboratories Ltd |
5-ht2b receptor antagonists
|
|
US7442697B2
(en)
|
2002-03-09 |
2008-10-28 |
Astrazeneca Ab |
4-imidazolyl substituted pyrimidine derivatives with CDK inhibitory activity
|
|
GB0205688D0
(en)
|
2002-03-09 |
2002-04-24 |
Astrazeneca Ab |
Chemical compounds
|
|
GB0205693D0
(en)
|
2002-03-09 |
2002-04-24 |
Astrazeneca Ab |
Chemical compounds
|
|
GB0205690D0
(en)
|
2002-03-09 |
2002-04-24 |
Astrazeneca Ab |
Chemical compounds
|
|
US6872724B2
(en)
|
2002-07-24 |
2005-03-29 |
Merck & Co., Inc. |
Polymorphs with tyrosine kinase activity
|
|
US20040023981A1
(en)
*
|
2002-07-24 |
2004-02-05 |
Yu Ren |
Salt forms with tyrosine kinase activity
|
|
US20040023978A1
(en)
*
|
2002-07-24 |
2004-02-05 |
Yu Ren |
Active salt forms with tyrosine kinase activity
|
|
ES2445208T3
(es)
*
|
2002-07-29 |
2014-02-28 |
Rigel Pharmaceuticals, Inc. |
Compuestos de 2,4-pirimidindiamina para uso en métodos para tratar o prevenir enfermedades autoinmunitarias
|
|
US7109337B2
(en)
*
|
2002-12-20 |
2006-09-19 |
Pfizer Inc |
Pyrimidine derivatives for the treatment of abnormal cell growth
|
|
OA13309A
(en)
*
|
2002-12-20 |
2007-04-13 |
Pfizer Prod Inc |
Pyrimidine derivatives for the treatment of abnormal cell growth.
|
|
UA80767C2
(en)
*
|
2002-12-20 |
2007-10-25 |
Pfizer Prod Inc |
Pyrimidine derivatives for the treatment of abnormal cell growth
|
|
GB0311276D0
(en)
|
2003-05-16 |
2003-06-18 |
Astrazeneca Ab |
Chemical compounds
|
|
GB0311274D0
(en)
|
2003-05-16 |
2003-06-18 |
Astrazeneca Ab |
Chemical compounds
|
|
WO2005012263A1
(en)
*
|
2003-07-24 |
2005-02-10 |
Pharmagene Laboratories Limited |
5-ht2b receptor antagonists
|
|
ES2320772T3
(es)
*
|
2003-07-25 |
2009-05-28 |
Ciba Holding Inc. |
Uso de 2,4-bis (alquilamino)pirimidinas sustituidas o quinazolinas como agentes antimicrobianos.
|
|
BRPI0413018B8
(pt)
*
|
2003-07-30 |
2021-05-25 |
Rigel Pharmaceuticals Inc |
composto, e, uso de um composto
|
|
JPWO2005040135A1
(ja)
*
|
2003-10-24 |
2007-03-08 |
小野薬品工業株式会社 |
抗ストレス薬およびその医薬用途
|
|
WO2005074643A2
(en)
*
|
2004-01-30 |
2005-08-18 |
Smithkline Beecham Corporation |
Benzamide compounds useful as rock inhibitors
|
|
TW200528101A
(en)
|
2004-02-03 |
2005-09-01 |
Astrazeneca Ab |
Chemical compounds
|
|
US20080161419A1
(en)
|
2004-02-20 |
2008-07-03 |
Shinobu Akuzawa |
Prophylactic Antimigraine Agents
|
|
WO2005099711A1
(en)
*
|
2004-04-13 |
2005-10-27 |
Icagen, Inc. |
Polycyclic pyrimidines as potassium ion channel modulators
|
|
US20060205945A1
(en)
*
|
2004-05-14 |
2006-09-14 |
Pfizer Inc |
Pyrimidine derivatives for the treatment of abnormal cell growth
|
|
MXPA06013165A
(es)
*
|
2004-05-14 |
2007-02-13 |
Pfizer Prod Inc |
Derivados de pirimidina para el tratamiento de crecimiento de celulas anormal.
|
|
WO2005111024A1
(en)
*
|
2004-05-14 |
2005-11-24 |
Pfizer Products Inc. |
Pyrimidine derivatives for the treatment of abnormal cell growth
|
|
MXPA06013164A
(es)
*
|
2004-05-14 |
2007-02-13 |
Pfizer Prod Inc |
Derivados de pirimidina para el tratamiento de crecimiento de celulas anormal.
|
|
US7820654B2
(en)
*
|
2004-09-23 |
2010-10-26 |
Dr. Reddy's Laboratories Ltd. |
Pyrimidine compounds, process for their preparation and compositions containing them
|
|
CN101031550B
(zh)
*
|
2004-09-30 |
2015-05-27 |
泰博特克药品有限公司 |
抑制hiv的5-碳环-或杂环取代的嘧啶类
|
|
GB2420559B
(en)
*
|
2004-11-15 |
2008-08-06 |
Rigel Pharmaceuticals Inc |
Stereoisomerically enriched 3-aminocarbonyl bicycloheptene pyrimidinediamine compounds and their uses
|
|
EP1814878B1
(en)
*
|
2004-11-24 |
2012-01-04 |
Rigel Pharmaceuticals, Inc. |
Spiro-2, 4-pyrimidinediamine compounds and their uses
|
|
GB0500492D0
(en)
*
|
2005-01-11 |
2005-02-16 |
Cyclacel Ltd |
Compound
|
|
DE602006010979D1
(de)
|
2005-01-19 |
2010-01-21 |
Rigel Pharmaceuticals Inc |
Prodrugs aus 2,4-pyrimidindiamin-verbindungen und ihre verwendungen
|
|
ES2533258T3
(es)
*
|
2005-02-18 |
2015-04-08 |
Janssen Sciences Ireland Uc |
Derivados de óxido de 2-(4-cianofenilamino)pirimidina que inhiben el VIH
|
|
CN101151249B
(zh)
*
|
2005-03-31 |
2011-04-06 |
辉瑞产品公司 |
环戊吡啶及四氢喹啉衍生物
|
|
EP1883302A4
(en)
*
|
2005-05-03 |
2009-05-20 |
Rigel Pharmaceuticals Inc |
JAK KINASE HEMMER AND ITS USE
|
|
US8193206B2
(en)
|
2005-06-14 |
2012-06-05 |
Taigen Biotechnology Co., Ltd. |
Pyrimidine compounds
|
|
JP5118029B2
(ja)
*
|
2005-06-14 |
2013-01-16 |
タイゲン バイオテクノロジー カンパニー，リミテッド |
ピリミジン化合物
|
|
EP1928236B1
(en)
*
|
2005-09-27 |
2011-11-23 |
Irm Llc |
Diarylamine-containing compounds and compositions, and their use as modulators of c-kit receptors
|
|
WO2007036732A1
(en)
|
2005-09-30 |
2007-04-05 |
Astrazeneca Ab |
Imidazo [1,2-a] pyridine having anti-cell-proliferation activity
|
|
WO2007062417A1
(en)
*
|
2005-11-28 |
2007-05-31 |
Kalypsys, Inc. |
Methods of preparing 2-imidazol-1-yl-4-methyl-6-pyrrolidin-2-yl-pyrimidine and 4-(1-alkylpyrrolidin-2-yl)-2-(1h-imidazol-1-yl)-6-methylpyrimidine derivatives
|
|
CN101384549B
(zh)
|
2006-02-20 |
2011-04-13 |
安斯泰来制药株式会社 |
吡咯衍生物或其盐
|
|
AR061185A1
(es)
|
2006-05-26 |
2008-08-13 |
Chugai Pharmaceutical Co Ltd |
Compuestos heterociclicos como inhibidores de hsp90. composiciones farmaceuticas.
|
|
JP2010514688A
(ja)
*
|
2006-12-22 |
2010-05-06 |
ノバルティス アーゲー |
インドール−４−イルピリミジニル−２−イル−アミン誘導体およびサイクリン依存性キナーゼ阻害剤としてのその使用
|
|
CA2679126A1
(en)
|
2007-03-01 |
2008-09-04 |
Chugai Seiyaku Kabushiki Kaisha |
Macrocyclic compound
|
|
BRPI0810411B8
(pt)
*
|
2007-04-18 |
2021-05-25 |
Pfizer Prod Inc |
derivados de sulfonil amida para o tratamento de crescimento celular anormal, seu sos, bem como composição farmacêutica
|
|
KR101294731B1
(ko)
*
|
2007-06-04 |
2013-08-16 |
삼성디스플레이 주식회사 |
어레이 기판, 이를 갖는 표시패널 및 이의 제조방법
|
|
CA2697081C
(en)
*
|
2007-08-22 |
2013-04-23 |
Irm Llc |
5-(4-(haloalkoxy)phenyl)pyrimidine-2-amine compounds and compositions as kinase inhibitors
|
|
RU2378278C2
(ru)
*
|
2008-01-24 |
2010-01-10 |
Андрей Александрович Иващенко |
ЗАМЕЩЕННЫЕ 3-СУЛЬФОНИЛ-[1,2,3]ТРИАЗОЛО[1,5-a]ПИРИМИДИНЫ-АНТАГОНИСТЫ СЕРОТОНИНОВЫХ 5-HT6 РЕЦЕПТОРОВ, СПОСОБЫ ИХ ПОЛУЧЕНИЯ И ПРИМЕНЕНИЕ
|
|
BRPI0908098A2
(pt)
|
2008-02-19 |
2015-08-18 |
Adolor Corp |
Beloxepina, composição, métodos para tratar dor em um mamífero, para inibir a recaptação de ne, para antagonizar um receptor de 5ht2 e para tratar um distúrbio em um paciente que é responsivo ao tratamento com um composto nri e com um composto antagonista de 5ht2
|
|
AU2008355098B2
(en)
|
2008-04-21 |
2012-11-15 |
Gpcr Therapeutics, Inc |
Heterocyclic compounds
|
|
CN102438993A
(zh)
*
|
2009-05-19 |
2012-05-02 |
陶氏益农公司 |
用于控制真菌的化合物和方法
|
|
AU2010339531A1
(en)
|
2009-12-30 |
2012-08-23 |
Arqule, Inc. |
Substituted naphthalenyl-pyrimidine compounds
|
|
CN102786512A
(zh)
*
|
2012-05-31 |
2012-11-21 |
中国人民解放军军事医学科学院毒物药物研究所 |
N-芳基不饱和稠环叔胺类化合物及其制备方法和抗肿瘤应用
|
|
US10336768B2
(en)
|
2014-06-13 |
2019-07-02 |
Yuma Therapeutics, Inc. |
Pyrimidine compounds and methods using the same
|
|
CN104725322B
(zh)
*
|
2015-02-16 |
2017-05-24 |
同济大学 |
一种2‑胺基嘧啶类化合物及其制备方法
|
|
WO2016173438A1
(zh)
*
|
2015-04-29 |
2016-11-03 |
南京明德新药研发股份有限公司 |
稠环或三环芳基嘧啶化合物用作激酶抑制剂
|
|
RU2605265C1
(ru)
*
|
2015-10-06 |
2016-12-20 |
федеральное государственное бюджетное образовательное учреждение высшего образования "Санкт-Петербургская государственная химико-фармацевтическая академия" Министерства здравоохранения Российской Федерации (ФГБОУ ВО СПХФА Минздрава России) |
Анальгезирующее и противовоспалительное средство на основе 5-бутил-6-гидрокси-2-метилпиримидин-4(3h)-она
|
|
AU2017269335B2
(en)
|
2016-05-26 |
2021-07-01 |
Recurium Ip Holdings, Llc |
EGFR inhibitor compounds
|
|
US10793551B2
(en)
|
2017-10-19 |
2020-10-06 |
Effector Therapeutics Inc. |
Benzimidazole-indole inhibitors of Mnk1 and Mnk2
|
|
CN108904503B
(zh)
*
|
2018-07-02 |
2021-09-28 |
陕西科技大学 |
6-氯-5-硝基-2,4-二氨基嘧啶在治疗慢性粒细胞白血病药物中的应用
|
|
MY209362A
(en)
*
|
2019-06-06 |
2025-07-03 |
Arcus Biosciences Inc |
Processes for preparing aminopyrimidine compounds
|
|
AR122450A1
(es)
*
|
2020-05-08 |
2022-09-14 |
Lilly Co Eli |
Compuestos de (trifluorometil)pirimidin-2-amina
|
|
CN114907273B
(zh)
*
|
2022-06-09 |
2025-02-18 |
乐威医药（江苏）股份有限公司 |
2-氨基嘧啶-6-芳基化合物的制备方法
|